QUVIVIQ

Live / Registered — Registered (as of 06 Oct 2020)

What this means for you

Registered since 06 Oct 2020. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79274313
Registration number
6166353
Mark type
Stylized text
Filed
05 Nov 2019
Published for opposition
21 Jul 2020
Registered
06 Oct 2020
Attorney of record
Mary Margaret L. O'Donnell

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, brain haemorrhage and sequelae thereof, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, diseases and disorders of the central nervous system, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, and cancer

Owner

Prosecution history

  • 09 Sept 2026 — TEAS SECTION 71 RECEIVED
  • 06 Aug 2026 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
  • 06 Oct 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
  • 22 Aug 2025 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
  • 16 Aug 2024 — CHANGE OF NAME/ADDRESS REC'D FROM IB
  • 14 Feb 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 23 Jan 2021 — FINAL DISPOSITION NOTICE SENT TO IB
  • 23 Jan 2021 — FINAL DISPOSITION PROCESSED
  • 06 Jan 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 11 Dec 2020 — NEW REPRESENTATIVE AT IB RECEIVED
  • 06 Oct 2020 — REGISTERED-PRINCIPAL REGISTER
  • 31 Jul 2020 — NOTIFICATION PROCESSED BY IB
  • 21 Jul 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 21 Jul 2020 — PUBLISHED FOR OPPOSITION
  • 15 Jul 2020 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

View this trademark record on Marksy